EGFR AND HER2 EXON 20 INSERTIONS IN SOLID TUMOURS: FROM BIOLOGY TO TREATMENT
Protein tyrosine kinases of the human epidermal growth factor receptor family, including EGFR and HER2, have emerged as important therapeutic targets in non-small-cell lung, breast and gastroesophageal cancers, and are of relevance for the treatment of various other malignancies (particularly colorectal cancer). Classic activating EGFR exon 19 deletions and exon 21 mutations, and HER2 amplification and/or overexpression, are predictive […]
EGFR AND HER2 EXON 20 INSERTIONS IN SOLID TUMOURS: FROM BIOLOGY TO TREATMENT Read More »
